The global Thalassemia market was valued at US$ 3014.5 million in 2023 and is anticipated to reach US$ 5386 million by 2030, witnessing a CAGR of 8.5% during the forecast period 2024-2030.

Thalassemia Market

Thalassemia is a blood disorder passed down through families (inherited) in which the body makes an abnormal form or inadequate amount of hemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen. The disorder results in large numbers of red blood cells being destroyed, which leads to anemia.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Thalassemia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thalassemia.

Report Scope

The Thalassemia market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thalassemia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Thalassemia companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Thalassemia Market Report

Report Metric	Details
Report Name	Thalassemia Market
Accounted market size in 2023	US$ 3014.5 million
Forecasted market size in 2030	US$ 5386 million
CAGR	8.5%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Iron Chelating Drugs Others
Segment by Application	Hospital Clinic Research Institute Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bluebird bio, Inc., Acceleron Pharma, Inc., Celgene Corporation, GlaxoSmithKline plc, Incyte Corporation, Gamida Cell, Kiadis Pharma, La Jolla Pharmaceutical Company, IONIS Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Thalassemia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Thalassemia Market growing?

Ans: The Thalassemia Market witnessing a CAGR of 8.5% during the forecast period 2024-2030.

What is the Thalassemia Market size in 2030?

Ans: The Thalassemia Market size in 2030 will be US$ 5386 million.

Who are the main players in the Thalassemia Market report?

Ans: The main players in the Thalassemia Market are Bluebird bio, Inc., Acceleron Pharma, Inc., Celgene Corporation, GlaxoSmithKline plc, Incyte Corporation, Gamida Cell, Kiadis Pharma, La Jolla Pharmaceutical Company, IONIS Pharmaceuticals

What are the Application segmentation covered in the Thalassemia Market report?

Ans: The Applications covered in the Thalassemia Market report are Hospital, Clinic, Research Institute, Laboratories, Others

What are the Type segmentation covered in the Thalassemia Market report?

Ans: The Types covered in the Thalassemia Market report are Iron Chelating Drugs, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Thalassemia Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Iron Chelating Drugs

1.2.3 Others

1.3 Market by Application

1.3.1 Global Thalassemia Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Research Institute

1.3.5 Laboratories

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Thalassemia Market Perspective (2019-2030)

2.2 Thalassemia Growth Trends by Region

2.2.1 Global Thalassemia Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Thalassemia Historic Market Size by Region (2019-2024)

2.2.3 Thalassemia Forecasted Market Size by Region (2025-2030)

2.3 Thalassemia Market Dynamics

2.3.1 Thalassemia Industry Trends

2.3.2 Thalassemia Market Drivers

2.3.3 Thalassemia Market Challenges

2.3.4 Thalassemia Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Thalassemia Players by Revenue

3.1.1 Global Top Thalassemia Players by Revenue (2019-2024)

3.1.2 Global Thalassemia Revenue Market Share by Players (2019-2024)

3.2 Global Thalassemia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Thalassemia Revenue

3.4 Global Thalassemia Market Concentration Ratio

3.4.1 Global Thalassemia Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Thalassemia Revenue in 2023

3.5 Thalassemia Key Players Head office and Area Served

3.6 Key Players Thalassemia Product Solution and Service

3.7 Date of Enter into Thalassemia Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Thalassemia Breakdown Data by Type

4.1 Global Thalassemia Historic Market Size by Type (2019-2024)

4.2 Global Thalassemia Forecasted Market Size by Type (2025-2030)

5 Thalassemia Breakdown Data by Application

5.1 Global Thalassemia Historic Market Size by Application (2019-2024)

5.2 Global Thalassemia Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Thalassemia Market Size (2019-2030)

6.2 North America Thalassemia Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Thalassemia Market Size by Country (2019-2024)

6.4 North America Thalassemia Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Thalassemia Market Size (2019-2030)

7.2 Europe Thalassemia Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Thalassemia Market Size by Country (2019-2024)

7.4 Europe Thalassemia Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Thalassemia Market Size (2019-2030)

8.2 Asia-Pacific Thalassemia Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Thalassemia Market Size by Region (2019-2024)

8.4 Asia-Pacific Thalassemia Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Thalassemia Market Size (2019-2030)

9.2 Latin America Thalassemia Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Thalassemia Market Size by Country (2019-2024)

9.4 Latin America Thalassemia Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Thalassemia Market Size (2019-2030)

10.2 Middle East & Africa Thalassemia Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Thalassemia Market Size by Country (2019-2024)

10.4 Middle East & Africa Thalassemia Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bluebird bio, Inc.

11.1.1 Bluebird bio, Inc. Company Detail

11.1.2 Bluebird bio, Inc. Business Overview

11.1.3 Bluebird bio, Inc. Thalassemia Introduction

11.1.4 Bluebird bio, Inc. Revenue in Thalassemia Business (2019-2024)

11.1.5 Bluebird bio, Inc. Recent Development

11.2 Acceleron Pharma, Inc.

11.2.1 Acceleron Pharma, Inc. Company Detail

11.2.2 Acceleron Pharma, Inc. Business Overview

11.2.3 Acceleron Pharma, Inc. Thalassemia Introduction

11.2.4 Acceleron Pharma, Inc. Revenue in Thalassemia Business (2019-2024)

11.2.5 Acceleron Pharma, Inc. Recent Development

11.3 Celgene Corporation

11.3.1 Celgene Corporation Company Detail

11.3.2 Celgene Corporation Business Overview

11.3.3 Celgene Corporation Thalassemia Introduction

11.3.4 Celgene Corporation Revenue in Thalassemia Business (2019-2024)

11.3.5 Celgene Corporation Recent Development

11.4 GlaxoSmithKline plc

11.4.1 GlaxoSmithKline plc Company Detail

11.4.2 GlaxoSmithKline plc Business Overview

11.4.3 GlaxoSmithKline plc Thalassemia Introduction

11.4.4 GlaxoSmithKline plc Revenue in Thalassemia Business (2019-2024)

11.4.5 GlaxoSmithKline plc Recent Development

11.5 Incyte Corporation

11.5.1 Incyte Corporation Company Detail

11.5.2 Incyte Corporation Business Overview

11.5.3 Incyte Corporation Thalassemia Introduction

11.5.4 Incyte Corporation Revenue in Thalassemia Business (2019-2024)

11.5.5 Incyte Corporation Recent Development

11.6 Gamida Cell

11.6.1 Gamida Cell Company Detail

11.6.2 Gamida Cell Business Overview

11.6.3 Gamida Cell Thalassemia Introduction

11.6.4 Gamida Cell Revenue in Thalassemia Business (2019-2024)

11.6.5 Gamida Cell Recent Development

11.7 Kiadis Pharma

11.7.1 Kiadis Pharma Company Detail

11.7.2 Kiadis Pharma Business Overview

11.7.3 Kiadis Pharma Thalassemia Introduction

11.7.4 Kiadis Pharma Revenue in Thalassemia Business (2019-2024)

11.7.5 Kiadis Pharma Recent Development

11.8 La Jolla Pharmaceutical Company

11.8.1 La Jolla Pharmaceutical Company Company Detail

11.8.2 La Jolla Pharmaceutical Company Business Overview

11.8.3 La Jolla Pharmaceutical Company Thalassemia Introduction

11.8.4 La Jolla Pharmaceutical Company Revenue in Thalassemia Business (2019-2024)

11.8.5 La Jolla Pharmaceutical Company Recent Development

11.9 IONIS Pharmaceuticals

11.9.1 IONIS Pharmaceuticals Company Detail

11.9.2 IONIS Pharmaceuticals Business Overview

11.9.3 IONIS Pharmaceuticals Thalassemia Introduction

11.9.4 IONIS Pharmaceuticals Revenue in Thalassemia Business (2019-2024)

11.9.5 IONIS Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

La Jolla Pharmaceutical Company

Ionis Pharmaceuticals

List of Tables

Table 1. Global Thalassemia Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Iron Chelating Drugs

Table 3. Key Players of Others

Table 4. Global Thalassemia Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Thalassemia Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Thalassemia Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Thalassemia Market Share by Region (2019-2024)

Table 8. Global Thalassemia Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Thalassemia Market Share by Region (2025-2030)

Table 10. Thalassemia Market Trends

Table 11. Thalassemia Market Drivers

Table 12. Thalassemia Market Challenges

Table 13. Thalassemia Market Restraints

Table 14. Global Thalassemia Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Thalassemia Market Share by Players (2019-2024)

Table 16. Global Top Thalassemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thalassemia as of 2023)

Table 17. Ranking of Global Top Thalassemia Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Thalassemia Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Thalassemia Product Solution and Service

Table 21. Date of Enter into Thalassemia Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Thalassemia Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Thalassemia Revenue Market Share by Type (2019-2024)

Table 25. Global Thalassemia Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Thalassemia Revenue Market Share by Type (2025-2030)

Table 27. Global Thalassemia Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Thalassemia Revenue Market Share by Application (2019-2024)

Table 29. Global Thalassemia Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Thalassemia Revenue Market Share by Application (2025-2030)

Table 31. North America Thalassemia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Thalassemia Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Thalassemia Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Thalassemia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Thalassemia Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Thalassemia Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Thalassemia Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Thalassemia Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Thalassemia Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Thalassemia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Thalassemia Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Thalassemia Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Thalassemia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Thalassemia Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Thalassemia Market Size by Country (2025-2030) & (US$ Million)

Table 46. Bluebird bio, Inc. Company Detail

Table 47. Bluebird bio, Inc. Business Overview

Table 48. Bluebird bio, Inc. Thalassemia Product

Table 49. Bluebird bio, Inc. Revenue in Thalassemia Business (2019-2024) & (US$ Million)

Table 50. Bluebird bio, Inc. Recent Development

Table 51. Acceleron Pharma, Inc. Company Detail

Table 52. Acceleron Pharma, Inc. Business Overview

Table 53. Acceleron Pharma, Inc. Thalassemia Product

Table 54. Acceleron Pharma, Inc. Revenue in Thalassemia Business (2019-2024) & (US$ Million)

Table 55. Acceleron Pharma, Inc. Recent Development

Table 56. Celgene Corporation Company Detail

Table 57. Celgene Corporation Business Overview

Table 58. Celgene Corporation Thalassemia Product

Table 59. Celgene Corporation Revenue in Thalassemia Business (2019-2024) & (US$ Million)

Table 60. Celgene Corporation Recent Development

Table 61. GlaxoSmithKline plc Company Detail

Table 62. GlaxoSmithKline plc Business Overview

Table 63. GlaxoSmithKline plc Thalassemia Product

Table 64. GlaxoSmithKline plc Revenue in Thalassemia Business (2019-2024) & (US$ Million)

Table 65. GlaxoSmithKline plc Recent Development

Table 66. Incyte Corporation Company Detail

Table 67. Incyte Corporation Business Overview

Table 68. Incyte Corporation Thalassemia Product

Table 69. Incyte Corporation Revenue in Thalassemia Business (2019-2024) & (US$ Million)

Table 70. Incyte Corporation Recent Development

Table 71. Gamida Cell Company Detail

Table 72. Gamida Cell Business Overview

Table 73. Gamida Cell Thalassemia Product

Table 74. Gamida Cell Revenue in Thalassemia Business (2019-2024) & (US$ Million)

Table 75. Gamida Cell Recent Development

Table 76. Kiadis Pharma Company Detail

Table 77. Kiadis Pharma Business Overview

Table 78. Kiadis Pharma Thalassemia Product

Table 79. Kiadis Pharma Revenue in Thalassemia Business (2019-2024) & (US$ Million)

Table 80. Kiadis Pharma Recent Development

Table 81. La Jolla Pharmaceutical Company Company Detail

Table 82. La Jolla Pharmaceutical Company Business Overview

Table 83. La Jolla Pharmaceutical Company Thalassemia Product

Table 84. La Jolla Pharmaceutical Company Revenue in Thalassemia Business (2019-2024) & (US$ Million)

Table 85. La Jolla Pharmaceutical Company Recent Development

Table 86. IONIS Pharmaceuticals Company Detail

Table 87. IONIS Pharmaceuticals Business Overview

Table 88. IONIS Pharmaceuticals Thalassemia Product

Table 89. IONIS Pharmaceuticals Revenue in Thalassemia Business (2019-2024) & (US$ Million)

Table 90. IONIS Pharmaceuticals Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Thalassemia Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Thalassemia Market Share by Type: 2023 VS 2030

Figure 3. Iron Chelating Drugs Features

Figure 4. Others Features

Figure 5. Global Thalassemia Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Thalassemia Market Share by Application: 2023 VS 2030

Figure 7. Hospital Case Studies

Figure 8. Clinic Case Studies

Figure 9. Research Institute Case Studies

Figure 10. Laboratories Case Studies

Figure 11. Others Case Studies

Figure 12. Thalassemia Report Years Considered

Figure 13. Global Thalassemia Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Thalassemia Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Thalassemia Market Share by Region: 2023 VS 2030

Figure 16. Global Thalassemia Market Share by Players in 2023

Figure 17. Global Top Thalassemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thalassemia as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Thalassemia Revenue in 2023

Figure 19. North America Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Thalassemia Market Share by Country (2019-2030)

Figure 21. United States Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Thalassemia Market Share by Country (2019-2030)

Figure 25. Germany Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Thalassemia Market Share by Region (2019-2030)

Figure 33. China Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Thalassemia Market Share by Country (2019-2030)

Figure 41. Mexico Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Thalassemia Market Share by Country (2019-2030)

Figure 45. Turkey Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Thalassemia Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Bluebird bio, Inc. Revenue Growth Rate in Thalassemia Business (2019-2024)

Figure 48. Acceleron Pharma, Inc. Revenue Growth Rate in Thalassemia Business (2019-2024)

Figure 49. Celgene Corporation Revenue Growth Rate in Thalassemia Business (2019-2024)

Figure 50. GlaxoSmithKline plc Revenue Growth Rate in Thalassemia Business (2019-2024)

Figure 51. Incyte Corporation Revenue Growth Rate in Thalassemia Business (2019-2024)

Figure 52. Gamida Cell Revenue Growth Rate in Thalassemia Business (2019-2024)

Figure 53. Kiadis Pharma Revenue Growth Rate in Thalassemia Business (2019-2024)

Figure 54. La Jolla Pharmaceutical Company Revenue Growth Rate in Thalassemia Business (2019-2024)

Figure 55. IONIS Pharmaceuticals Revenue Growth Rate in Thalassemia Business (2019-2024)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions